Heart Test Laboratories Net Income
| HSCSW Stock | USD 0.11 0.00 0.00% |
As of the 3rd of February, Heart Test retains the market risk adjusted performance of 2.58, and Risk Adjusted Performance of 0.1534. Heart Test technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Heart Test Laboratories standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Heart Test is priced fairly, providing market reflects its last-minute price of 0.11 per share. As Heart Test Laboratories appears to be a penny stock we also urge to confirm its total risk alpha numbers.
Heart Test's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Heart Test's valuation are provided below:Heart Test Laboratories does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. What growth prospects exist in Stock sector? Can Heart capture new markets? Factors like these will boost the valuation of Heart Test. Market participants price Heart higher when confident in its future expansion prospects. Valuation analysis balances hard financial data with qualitative growth assessments. While each Heart Test valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Investors evaluate Heart Test Laboratories using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Heart Test's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. External factors like market trends, sector rotation, and investor psychology can cause Heart Test's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Heart Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heart Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Heart Test's market price signifies the transaction level at which participants voluntarily complete trades.
Heart Test 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Heart Test's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Heart Test.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Heart Test on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Heart Test Laboratories or generate 0.0% return on investment in Heart Test over 90 days. Heart Test is related to or competes with Bone Biologics, Venus Concept, Shuttle Pharmaceuticals, Catheter Precision, Movano, Bluejay Diagnostics, and GlucoTrack. Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices More
Heart Test Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Heart Test's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Heart Test Laboratories upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 31.38 | |||
| Information Ratio | 0.1948 | |||
| Maximum Drawdown | 274.83 | |||
| Value At Risk | (42.07) | |||
| Potential Upside | 71.84 |
Heart Test Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heart Test's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Heart Test's standard deviation. In reality, there are many statistical measures that can use Heart Test historical prices to predict the future Heart Test's volatility.| Risk Adjusted Performance | 0.1534 | |||
| Jensen Alpha | 10.11 | |||
| Total Risk Alpha | 7.01 | |||
| Sortino Ratio | 0.3267 | |||
| Treynor Ratio | 2.57 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Heart Test's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Heart Test February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1534 | |||
| Market Risk Adjusted Performance | 2.58 | |||
| Mean Deviation | 30.91 | |||
| Semi Deviation | 23.27 | |||
| Downside Deviation | 31.38 | |||
| Coefficient Of Variation | 510.55 | |||
| Standard Deviation | 52.62 | |||
| Variance | 2768.57 | |||
| Information Ratio | 0.1948 | |||
| Jensen Alpha | 10.11 | |||
| Total Risk Alpha | 7.01 | |||
| Sortino Ratio | 0.3267 | |||
| Treynor Ratio | 2.57 | |||
| Maximum Drawdown | 274.83 | |||
| Value At Risk | (42.07) | |||
| Potential Upside | 71.84 | |||
| Downside Variance | 984.47 | |||
| Semi Variance | 541.37 | |||
| Expected Short fall | (48.73) | |||
| Skewness | 2.91 | |||
| Kurtosis | 11.96 |
Heart Test Laboratories Backtested Returns
Heart Test is out of control given 3 months investment horizon. Heart Test Laboratories holds Efficiency (Sharpe) Ratio of 0.2, which attests that the entity had a 0.2 % return per unit of standard deviation over the last 3 months. We are able to interpolate and collect twenty-five different technical indicators, which can help you to evaluate if expected returns of 10.31% are justified by taking the suggested risk. Use Heart Test Laboratories market risk adjusted performance of 2.58, and Risk Adjusted Performance of 0.1534 to evaluate company specific risk that cannot be diversified away. Heart Test holds a performance score of 15 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 4.01, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Heart Test will likely underperform. Use Heart Test Laboratories information ratio, as well as the relationship between the value at risk and kurtosis , to analyze future returns on Heart Test Laboratories.
Auto-correlation | -0.08 |
Very weak reverse predictability
Heart Test Laboratories has very weak reverse predictability. Overlapping area represents the amount of predictability between Heart Test time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Heart Test Laboratories price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Heart Test price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Heart Test Laboratories reported net income of (8.77 Million). This is 102.57% lower than that of the Health Care Equipment & Supplies sector and 103.68% lower than that of the Health Care industry. The net income for all United States stocks is 101.54% higher than that of the company.
Heart Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heart Test's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics of similar companies.Heart Test is currently under evaluation in net income category among its peers.
Heart Fundamentals
| Return On Equity | -2.2 | |||
| Return On Asset | -0.75 | |||
| Operating Margin | (857.13) % | |||
| Number Of Shares Shorted | 13 | |||
| Revenue | 4.35 K | |||
| Gross Profit | 5.02 K | |||
| EBITDA | (8.14 M) | |||
| Net Income | (8.77 M) | |||
| Cash And Equivalents | 723.48 K | |||
| Cash Per Share | 0.22 X | |||
| Total Debt | 2.99 M | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | 1.36 X | |||
| Cash Flow From Operations | (7.41 M) | |||
| Earnings Per Share | (1.09) X | |||
| Number Of Employees | 15 | |||
| Beta | 2.54 | |||
| Total Asset | 4.22 M | |||
| Retained Earnings | (76.13 M) | |||
| Working Capital | (1.53 M) | |||
| Net Asset | 4.22 M |
About Heart Test Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heart Test Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heart Test using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heart Test Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.